UNSPSC 51351517: Hydroxyprogesterone

This classification denotes a therapeutic progestin with the molecular formula C21H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21807M87J2, chemically known as 17-hydroxypregn-4-ene-3,20-dione but generally known as 17alpha-hydroxyprogesterone, which bears US NIH Compound Identifier 6238. European Medicines Agency schedules Hydroxyprogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08081MIG. The term 17ALPHA-HYDROXYPROGESTERONE is an International Non-Proprietary Name.

UNSPSC 51351517 Hydroxyprogesterone is a Commodity code covering active pharmaceutical ingredients and finished-dose hormone medications used by state and local health systems, correctional facilities, and Medicaid programs. State and local procurement under this code focuses on acquiring hydroxyprogesterone products — including generic multi-source formulations and brand alternatives — through cooperative purchasing agreements that aggregate demand across multiple jurisdictions and negotiate volume pricing with manufacturers and authorized drug wholesalers. Issuing bodies include state pharmacy benefit managers, Medicaid agencies, cooperative purchasing alliances, and departments of health and human services; procurement typically occurs through RFPs that establish master agreements with multiple vendors rather than individual purchase orders.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) for a multi-state Generic Multi Source Pharmaceuticals and OTC Products contract spanning Minnesota and Oregon. MMCAP's award will supply three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) beginning July 1, 2026, with evaluation weighted heavily on price competitiveness (75 percent) and flexibility in pricing structures (flat price, net price formats, or WAC-minus). Vendors must maintain relationships with at least two of the three wholesalers, certify cGMP and DSCSA compliance, carry $5 million general liability coverage, and accept a 3 percent administrative fee on all purchases. The contract term is two years for new vendors with optional extensions at MMCAP's discretion. No set-aside designations appear in the available RFP documentation, and specific award values are not disclosed.